Testimonial from Dr. Meier from Swedish cancer center. He reports on the results from clinical study on prostate SBRT.
Dr. Robert Meier from Swedish cancer center in Seattle reports on the results at 5 years from a prospective, multi-institutional clinical study for low and intermediate risk prostate cancer. The study included 21 centers and 309 patients treated with CyberKnife. The efficacy and toxicity rates compare favorably to conventional radiotherapy and the treatment is more convenient for patients compare to conventional radiotherapy.